Insights into clonal and complete blood count changes at disease evolution among patients with clonal cytopenia of undetermined significance
Yazan Jabban(Mayo Clinic), Aref Al-Kali(Mayo Clinic), Hassan B. Alkhateeb(Mayo Clinic), Yael Kusne(WinnMed), Mrinal M. Patnaik(Mayo Clinic), PR Greipp(Mayo Clinic), Talha Badar(Jacksonville College), Dragan Jevremovic(Mayo Clinic), Kurt Bessonen(Mayo Clinic), Rong He(Mayo Clinic), David S. Viswanatha(Mayo Clinic), William J. Hogan(Mayo Clinic), Mithun Vinod Shah(Mayo Clinic), Cecilia Arana Yi(WinnMed), Abhishek A. Mangaonkar(Mayo Clinic), Aasiya Matin(Mayo Clinic), Antoine N. Saliba(Mayo Clinic in Arizona), James M. Foran(WinnMed), M. Hefazi(Mayo Clinic)
Cited by 0
Related Papers
Inherited antithrombin deficiency: a review
|Haemophilia|2008|396
Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease
|Haematologica|2019|215
Reduced Posterior Cingulate Mitochondrial Activity in Expired Young Adult Carriers of the APOE ε4 Allele, the Major Late-Onset Alzheimer's Susceptibility Gene
|Journal of Alzheimer s Disease|2010|155
Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients
|American Journal of Hematology|2020|136
Bi- and uniciliated ependymal cells define continuous floor-plate-derived tanycytic territories
|Nature Communications|2017|115